Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 673

1.

Phase I/II trial of vorinostat, bevacizumab, and daily temozolomide for recurrent malignant gliomas.

Peters KB, Lipp ES, Miller E, Herndon JE 2nd, McSherry F, Desjardins A, Reardon DA, Friedman HS.

J Neurooncol. 2017 Dec 21. doi: 10.1007/s11060-017-2724-1. [Epub ahead of print]

PMID:
29264836
2.

Phase II Study of Bevacizumab and Vorinostat for Patients with Recurrent World Health Organization Grade 4 Malignant Glioma.

Ghiaseddin A, Reardon D, Massey W, Mannerino A, Lipp ES, Herndon JE 2nd, McSherry F, Desjardins A, Randazzo D, Friedman HS, Peters KB.

Oncologist. 2018 Feb;23(2):157-e21. doi: 10.1634/theoncologist.2017-0501. Epub 2017 Nov 13.

PMID:
29133513
3.

Adaptive Evolution of the GDH2 Allosteric Domain Promotes Gliomagenesis by Resolving IDH1R132H-Induced Metabolic Liabilities.

Waitkus MS, Pirozzi CJ, Moure CJ, Diplas BH, Hansen LJ, Carpenter AB, Yang R, Wang Z, Ingram BO, Karoly ED, Mohney RP, Spasojevic I, McLendon RE, Friedman HS, He Y, Bigner DD, Yan H.

Cancer Res. 2018 Jan 1;78(1):36-50. doi: 10.1158/0008-5472.CAN-17-1352. Epub 2017 Nov 2.

PMID:
29097607
4.

Dendritic Cells Enhance Polyfunctionality of Adoptively Transferred T Cells That Target Cytomegalovirus in Glioblastoma.

Reap EA, Suryadevara CM, Batich KA, Sanchez-Perez L, Archer GE, Schmittling RJ, Norberg PK, Herndon JE 2nd, Healy P, Congdon KL, Gedeon PC, Campbell OC, Swartz AM, Riccione KA, Yi JS, Hossain-Ibrahim MK, Saraswathula A, Nair SK, Dunn-Pirio AM, Broome TM, Weinhold KJ, Desjardins A, Vlahovic G, McLendon RE, Friedman AH, Friedman HS, Bigner DD, Fecci PE, Mitchell DA, Sampson JH.

Cancer Res. 2018 Jan 1;78(1):256-264. doi: 10.1158/0008-5472.CAN-17-0469. Epub 2017 Nov 1.

PMID:
29093005
5.

The national burden of poorly controlled asthma, school absence and parental work loss among school-aged children in the United States.

Sullivan PW, Ghushchyan V, Navaratnam P, Friedman HS, Kavati A, Ortiz B, Lanier B.

J Asthma. 2017 Oct 5:1-9. doi: 10.1080/02770903.2017.1350972. [Epub ahead of print]

PMID:
28981368
6.

The national cost of asthma among school-aged children in the United States.

Sullivan PW, Ghushchyan V, Navaratnam P, Friedman HS, Kavati A, Ortiz B, Lanier B.

Ann Allergy Asthma Immunol. 2017 Sep;119(3):246-252.e1. doi: 10.1016/j.anai.2017.07.002.

PMID:
28890020
7.

Scaling up family planning in Sierra Leone: A prospective cost-benefit analysis.

Keen S, Begum H, Friedman HS, James CD.

Womens Health (Lond). 2017 Dec;13(3):43-57. doi: 10.1177/1745505717724617. Epub 2017 Aug 29.

PMID:
28849728
8.

National Prevalence of Poor Asthma Control and Associated Outcomes among School-Aged Children in the United States.

Sullivan PW, Ghushchyan V, Navaratnam P, Friedman HS, Kavati A, Ortiz B, Lanier B.

J Allergy Clin Immunol Pract. 2017 Aug 25. pii: S2213-2198(17)30525-1. doi: 10.1016/j.jaip.2017.06.039. [Epub ahead of print]

PMID:
28847656
9.

Animation Stimuli System for Research on Instructor Gestures in Education.

Cui J, Popescu V, Adamo-Villani N, Wagner Cook S, Duggan KA, Friedman HS.

IEEE Comput Graph Appl. 2017;37(4):72-83. doi: 10.1109/MCG.2017.3271471.

PMID:
28829295
10.

Indicators of poorly controlled asthma and health-related quality of life among school-age children in the United States.

Sullivan PW, Ghushchyan V, Navaratnam P, Friedman HS, Kavati A, Ortiz B, Lanier B.

Allergy Asthma Proc. 2017 Nov 11;38(6):431-439. doi: 10.2500/aap.2017.38.4084. Epub 2017 Aug 11.

PMID:
28800789
11.

A cross sectional analysis from a single institution's experience of psychosocial distress and health-related quality of life in the primary brain tumor population.

Randazzo DM, McSherry F, Herndon JE 2nd, Affronti ML, Lipp ES, Flahiff C, Miller E, Woodring S, Freeman M, Healy P, Minchew J, Boulton S, Desjardins A, Vlahovic G, Friedman HS, Keir S, Peters KB.

J Neurooncol. 2017 Sep;134(2):363-369. doi: 10.1007/s11060-017-2535-4. Epub 2017 Jul 1.

PMID:
28669010
12.

Assessment of treatment patterns associated with injectable disease-modifying therapy among relapsing-remitting multiple sclerosis patients.

Nicholas J, Ko JJ, Park Y, Navaratnam P, Friedman HS, Ernst FR, Herrera V.

Mult Scler J Exp Transl Clin. 2017 Mar 17;3(1):2055217317696114. doi: 10.1177/2055217317696114. eCollection 2017 Jan-Mar.

13.

The case for investing in the male condom.

Stover J, Rosen JE, Carvalho MN, Korenromp EL, Friedman HS, Cogan M, Deperthes B.

PLoS One. 2017 May 16;12(5):e0177108. doi: 10.1371/journal.pone.0177108. eCollection 2017.

14.

School absence and productivity outcomes associated with childhood asthma in the USA.

Sullivan P, Ghushchyan VG, Navaratnam P, Friedman HS, Kavati A, Ortiz B, Lanier B.

J Asthma. 2018 Feb;55(2):161-168. doi: 10.1080/02770903.2017.1313273. Epub 2017 Apr 28.

PMID:
28453370
15.

Building the foundations for sustainable development: a case for global investment in the capabilities of adolescents.

Sheehan P, Sweeny K, Rasmussen B, Wils A, Friedman HS, Mahon J, Patton GC, Sawyer SM, Howard E, Symons J, Stenberg K, Chalasani S, Maharaj N, Reavley N, Shi H, Fridman M, Welsh A, Nsofor E, Laski L.

Lancet. 2017 Oct 14;390(10104):1792-1806. doi: 10.1016/S0140-6736(17)30872-3. Epub 2017 Apr 19.

PMID:
28433259
16.

Long-term Survival in Glioblastoma with Cytomegalovirus pp65-Targeted Vaccination.

Batich KA, Reap EA, Archer GE, Sanchez-Perez L, Nair SK, Schmittling RJ, Norberg P, Xie W, Herndon JE 2nd, Healy P, McLendon RE, Friedman AH, Friedman HS, Bigner D, Vlahovic G, Mitchell DA, Sampson JH.

Clin Cancer Res. 2017 Apr 15;23(8):1898-1909. doi: 10.1158/1078-0432.CCR-16-2057.

PMID:
28411277
17.

A Phase II single-arm trial of palonosetron for the prevention of acute and delayed chemotherapy-induced nausea and vomiting in malignant glioma patients receiving multidose irinotecan in combination with bevacizumab.

Affronti ML, Woodring S, Peters KB, Herndon JE 2nd, McSherry F, Healy PN, Desjardins A, Vredenburgh JJ, Friedman HS.

Ther Clin Risk Manag. 2016 Dec 23;13:33-40. doi: 10.2147/TCRM.S122480. eCollection 2017.

18.

A Phase II feasibility study of oral etoposide given concurrently with radiotherapy followed by dose intensive adjuvant chemotherapy for children with newly diagnosed high-risk medulloblastoma (protocol POG 9631): A report from the Children's Oncology Group.

Esbenshade AJ, Kocak M, Hershon L, Rousseau P, Decarie JC, Shaw S, Burger P, Friedman HS, Gajjar A, Moghrabi A.

Pediatr Blood Cancer. 2017 Jun;64(6). doi: 10.1002/pbc.26373. Epub 2016 Dec 21.

PMID:
28000417
20.

Association between cardiac, renal, and hepatic biomarkers and outcomes in patients with acute heart failure.

Chan WW, Waltman Johnson K, Friedman HS, Navaratnam P.

Hosp Pract (1995). 2016 Aug;44(3):138-45. doi: 10.1080/21548331.2016.1197760. Epub 2016 Jun 15.

PMID:
27292609

Supplemental Content

Loading ...
Support Center